aretediscoveries.com Reviews

Arête Discoveries is a biopharmaceutical discovery firm that focuses on developing treatments to stop the progression of autoimmune diseases. Their research is centered on the innate immune system and the epigenetic impact on tissues throughout the human body. The company’s primary target is neurodegeneration, specifically amyotrophic lateral sclerosis (ALS), a progressive and fatal neurodegenerative disease. Arête Discoveries claims to have a fresh approach to understanding autoimmune diseases, aiming to uncover previously unknown biological interactions.

The company is seeking support from various sources, including family foundations, private individuals, and collaboration with pharmaceutical companies and biopharma discovery firms. Arête Discoveries has filed national patent applications for method of use and composition of matter in several countries and claims success in stopping the progression of multiple sclerosis (MS) and Alzheimer’s disease in proof of concept mouse models. Their future targets for treatment include Parkinson’s disease, ALS, Hashimoto’s disease, Graves disease, Crohn’s disease, ulcerative colitis, and more.

The website provides a copyright notice for 2023 and is powered by GoDaddy. The SSL certificate is issued by GoDaddy Secure Certificate Authority – G2. The domain has been registered for over 8 years and 3 months, and the website has been archived by the Wayback Machine. The server information indicates that the website is hosted on Amazon Web Services.

Based on the information available, Arête Discoveries appears to be a legitimate biopharmaceutical company with a focus on innovative research and development in the field of autoimmune diseases, particularly ALS. However, as with any investment or collaboration opportunity, it’s important to conduct thorough due diligence and consider seeking professional advice before engaging with the company. This includes verifying their scientific claims, assessing their financial stability, and understanding the potential risks and benefits of any involvement with the organization.”

the reasons behind this review :
Biopharmaceutical company focused on developing treatments for autoimmune diseases, particularly ALS. Research centered on the innate immune system and epigenetic impact. Claims a fresh approach to understanding autoimmune diseases. Seeking support from family foundations, private individuals, and collaboration with pharmaceutical companies. Filed national patent applications for method of use and composition of matter in several countries. Claims success in stopping the progression of MS and Alzheimer's disease in proof of concept mouse models. Future targets for treatment include Parkinson's disease, ALS, Hashimoto's disease, Graves disease, Crohn's disease, ulcerative colitis, and more. Website has a copyright notice for 2023 and is powered by GoDaddy. SSL certificate issued by GoDaddy Secure Certificate Authority - G2. Domain registered for over 8 years and 3 months. Website has been archived by the Wayback Machine. Server information indicates hosting on Amazon Web Services.